Delivery Order SPE2DB22D2206-SPE2DB25FDP88

Award Date 10/4/24
Potential Completion Date 10/28/24
Potential Value $8.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $8,878.79 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide 4563518616 Mekinist 2 mg tablets, with a completion date of February 23, 2024. This contract is a part of AmerisourceBergen's broader Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets. The contract, which is not set aside, has a ceiling value of $2,589.70 and a completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, branded and generic drugs, vaccines, and...
This is a delivery order under a Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at up to $999,999,999 through December 2025, provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This specific delivery order, valued at $8,878.79, is for the Mekinist 2 mg tablet drug product. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,878.79 firm-fixed-price delivery order is for the supply of MEKINIST 2 MG TABLET medical products. The contract has an ultimate completion date of July 11, 2024 and was awarded on June 18, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $10,358.80 order is for the supply of Mekinist 0.5 mg tablets in support of military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA with a potential value of $999,999,999.00 through December 31, 2025, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MEKINIST 2 MG TABLET UU 30S, a prescription medication. The award, valued at $17,757.60, has an ultimate completion date of August 28, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $18,371.32 fixed-price award is for the delivery of 4,566,462,969 units of the drug MEKINIST 2 MG Tablet with a completion date of December 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the award is...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the delivery of MEKINIST 2 MG TABLET pharmaceutical products, with a ceiling value of $17,018.12 and a period of performance through April 22, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,878.79, is for the delivery of MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product, under a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of June 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of MEKINIST 2 MG tablets, a prescription medication, with a ceiling value of $82,134.30 and a completion date of February 28, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business category. Amerisourcebergen holds a larger...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDP88
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mekinist 2 mg tablets. The $8,878.79 firm-fixed price contract has an ultimate completion date of October 28, 2024. It does not have a set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen's federal contracting activities focus on supplying essential pharmaceutical and medical products to various government agencies and healthcare programs.

Generated 1/3/25, 9:31 AM